ScholarIQanswers from OpenAlex

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma

PaperCitations, authors & open-access status

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma have?

ScholarIQcitation count

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has 240 citations in the OpenAlex counts ScholarIQ stores.

When was The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma published?

ScholarIQyear

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has 2006 year in the ScholarIQ index.

What is the open-access status of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

ScholarIQoa status

The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma has closed oa status in the ScholarIQ index.

What is the DOI of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

ScholarIQdoi

The DOI for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

What is the PMID of The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

ScholarIQpmid

The PMID for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

What is the OpenAlex record for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma?

ScholarIQopenalex

The OpenAlex for The <i>BRAF</i> mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial